Home › Companies › ADICET BIO INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and ADICET BIO INC.’s Form 8-K, filed June 7, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 5, 2024: 7 items on ADICET BIO INC.’s Form 8-K, filed June 7, 2024: 5 approved · 2 passed (calculated).
Significant dissent: 1 director (22.6% against); 1 say-on-pay vote (60.9% support).
Notable dissent: 1 director (15.1% against); 1 other board item (41.3% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024
Activist investors: Ra Capital Management, L.P. (13F, 10.0%, as of September 30, 2026)
Explore ADICET BIO INC. in the interactive database Compare manager voting policies
These tallies are ADICET BIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 7, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael G. Kauffman, M.D., Ph.D. | 41,712,563 | -- | -- | 7,432,133 | 12,424,510 | 85% | Passed (calculated) | — |
| Elect Director: Andrew Sinclair, Ph.D. | 38,036,535 | -- | -- | 11,108,161 | 12,424,510 | 77% | Passed (calculated) | — |
| 2. Approval of an Amendment to Adicet Bio, Inc | 28,859,969 | 20,278,299 | 6,428 | -- | 12,424,510 | 59% | Approved | — |
| 3. Approval of an Amendment to Adicet Bio, Inc | 58,940,904 | 2,621,988 | 6,314 | -- | 12,424,510 | 96% | Approved | — |
| 4. Approval of an Amendment to Adicet Bio, Inc. Third Amended and Restated Certificate of Incorporation to Limit the Liability of Certain of the Company's Officers as Permitted by Delaware Law | 43,646,665 | 5,491,648 | 6,383 | -- | 12,424,510 | 89% | Approved | — |
| 5. Non-Binding Advisory Vote on Compensation of the Company's Named Executive Officers | 29,915,289 | 19,213,617 | 15,790 | -- | 12,424,510 | 61% | Approved | — |
| 7. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm | 61,549,197 | 8,657 | 11,352 | -- | -- | 99.9% | Approved | — |
Source: ADICET BIO INC., Form 8-K, filed with the SEC on June 7, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
104 asset managers disclosed a vote on at least one ADICET BIO INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of ADICET BIO INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: Andrew Sinclair, Ph.D.
ADICET BIO INC.’s own tally for this item (“Elect Director: Andrew Sinclair, Ph.D.”): 38,036,535 for, 11,108,161 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 77% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 3,460,690 for, 3,537,173 withheld, 210,372 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,187,084 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 1,512,659 | Withhold |
| Fidelity | 0 | 0 | 0 | 1,063,513 | Withhold |
| TIAA | 0 | 0 | 0 | 197,137 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 183,375 | Withhold |
| Charles Schwab | 150,076 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 140,011 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 129,800 | Withhold |
| TARGET PORTFOLIO TRUST | 103,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 99,541 | Withhold |
| Equitable | 0 | 0 | 0 | 88,344 | Withhold |
| American Century | 0 | 0 | 0 | 58,437 | Withhold |
| Dimensional | 0 | 0 | 0 | 36,397 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 30,929 | Withhold |
| Pacific Life | 0 | 0 | 0 | 23,780 | Withhold |
| Bridge Builder Trust | 0 | 0 | 21,312 | 0 | Abstain |
| Nationwide | 0 | 0 | 0 | 20,746 | Withhold |
| Voya | 0 | 0 | 0 | 20,267 | Withhold |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 0 | 18,074 | 0 | Abstain |
| John Hancock | 0 | 0 | 16,055 | 0 | Abstain |
| Jackson National | 0 | 0 | 14,920 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 12,488 | Withhold |
| HC CAPITAL TRUST | 0 | 0 | 0 | 10,211 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 7,842 | Withhold |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: To elect two class III directors, to serve for a three-year term ending at the Annual Meeting of Stockholders to be held in 2027: Michael G. Kauffman, M.D., Ph.D.
ADICET BIO INC.’s own tally for this item (“Elect Director: Michael G. Kauffman, M.D., Ph.D.”): 41,712,563 for, 7,432,133 withheld, per its Form 8-K filed June 7, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 6,081,247 for, 956,002 withheld, 170,986 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,187,084 | 0 | 0 | 0 | For |
| BlackRock | 1,512,659 | 0 | 0 | 0 | For |
| Fidelity | 867,606 | 0 | 0 | 195,907 | Mixed |
| TIAA | 0 | 0 | 0 | 197,137 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 183,375 | Withhold |
| Charles Schwab | 150,076 | 0 | 0 | 0 | For |
| ETF Series Solutions | 0 | 0 | 140,011 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 129,800 | Withhold |
| TARGET PORTFOLIO TRUST | 103,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 99,541 | 0 | 0 | 0 | For |
| Equitable | 51,604 | 0 | 0 | 36,740 | Mixed |
| American Century | 0 | 0 | 0 | 58,437 | Withhold |
| Dimensional | 0 | 0 | 0 | 36,397 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 30,929 | Withhold |
| Pacific Life | 23,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,312 | 0 | 0 | 0 | For |
| Nationwide | 0 | 0 | 0 | 20,746 | Withhold |
| Voya | 20,267 | 0 | 0 | 0 | For |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 18,074 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 16,055 | 0 | Abstain |
| Jackson National | 0 | 0 | 14,920 | 0 | Abstain |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 12,488 | Withhold |
| HC CAPITAL TRUST | 0 | 0 | 0 | 10,211 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 7,842 | Withhold |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
89% Approved · of votes cast
Description as filed by funds: To amend the Third Amended and Restated Certificate of Incorporation to limit the liability of certain of the Company's officers as permitted by Delaware law.
ADICET BIO INC.’s own tally for this item (“4. Approval of an Amendment to Adicet Bio, Inc. Third Amended and Restated Certificate of Incorporation to Limit the Liability of Certain of the Company's Officers as Permitted by Delaware Law”): 43,646,665 for, 5,491,648 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4- Approval of an Amendment to Adicet Bio, Inc. Third Amended and Restated Certificate of Incorporation to Limit the Liability of Certain of the Company's Officers as Permitted by Delaware Law The stockholders of the Company approved the Exculpation Amendment to limit the liability of cert…”
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 7,175,217 for, 33,018 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,187,084 | 0 | 0 | 0 | For |
| BlackRock | 1,512,659 | 0 | 0 | 0 | For |
| Fidelity | 1,063,513 | 0 | 0 | 0 | For |
| TIAA | 197,137 | 0 | 0 | 0 | For |
| Goldman Sachs | 183,375 | 0 | 0 | 0 | For |
| Charles Schwab | 150,076 | 0 | 0 | 0 | For |
| ETF Series Solutions | 140,011 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 129,800 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 103,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 99,541 | 0 | 0 | 0 | For |
| Equitable | 88,344 | 0 | 0 | 0 | For |
| American Century | 58,437 | 0 | 0 | 0 | For |
| Dimensional | 36,397 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,929 | 0 | 0 | 0 | For |
| Pacific Life | 23,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,312 | 0 | 0 | 0 | For |
| Nationwide | 20,746 | 0 | 0 | 0 | For |
| Voya | 20,267 | 0 | 0 | 0 | For |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 18,074 | 0 | 0 | Against |
| John Hancock | 16,055 | 0 | 0 | 0 | For |
| Jackson National | 14,920 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 12,488 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 0 | 10,211 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 7,842 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
98% of fund votes cast · no official result
Description as filed by funds: To amend the Third Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 150,000,000 to 300,000,000.
The 38 asset managers below reported 7,094,624 for, 113,611 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,187,084 | 0 | 0 | 0 | For |
| BlackRock | 1,512,659 | 0 | 0 | 0 | For |
| Fidelity | 1,063,513 | 0 | 0 | 0 | For |
| TIAA | 197,137 | 0 | 0 | 0 | For |
| Goldman Sachs | 183,375 | 0 | 0 | 0 | For |
| Charles Schwab | 150,076 | 0 | 0 | 0 | For |
| ETF Series Solutions | 140,011 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 129,800 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 0 | 103,400 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 99,541 | 0 | 0 | 0 | For |
| Equitable | 88,344 | 0 | 0 | 0 | For |
| American Century | 58,437 | 0 | 0 | 0 | For |
| Dimensional | 36,397 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,929 | 0 | 0 | 0 | For |
| Pacific Life | 23,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,312 | 0 | 0 | 0 | For |
| Nationwide | 20,746 | 0 | 0 | 0 | For |
| Voya | 20,267 | 0 | 0 | 0 | For |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 18,074 | 0 | 0 | 0 | For |
| John Hancock | 16,055 | 0 | 0 | 0 | For |
| Jackson National | 14,920 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 12,488 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 0 | 10,211 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 7,842 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
0.1% of fund votes cast · no official result
Description as filed by funds: To amend the Adicet Bio, Inc. Second Amended and Restated 2018 Stock Option and Incentive Plan to increase the number of shares of common stock authorized for issuance under the plan by 5,000,000 shares of common stock.
The 39 asset managers below reported 300 for, 7,208,235 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 3,187,084 | 0 | 0 | Against |
| BlackRock | 0 | 1,512,659 | 0 | 0 | Against |
| Fidelity | 0 | 1,063,513 | 0 | 0 | Against |
| TIAA | 0 | 197,137 | 0 | 0 | Against |
| Goldman Sachs | 0 | 183,375 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,076 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 140,011 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 129,800 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 0 | 103,400 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 99,541 | 0 | 0 | Against |
| Equitable | 0 | 88,344 | 0 | 0 | Against |
| American Century | 0 | 58,437 | 0 | 0 | Against |
| Dimensional | 0 | 36,397 | 0 | 0 | Against |
| Lincoln Financial | 0 | 30,929 | 0 | 0 | Against |
| Pacific Life | 0 | 23,780 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 21,312 | 0 | 0 | Against |
| Nationwide | 0 | 20,746 | 0 | 0 | Against |
| Voya | 0 | 20,267 | 0 | 0 | Against |
| Northern Trust | 0 | 19,898 | 0 | 0 | Against |
| Managed Portfolio Series | 0 | 18,074 | 0 | 0 | Against |
| John Hancock | 0 | 16,055 | 0 | 0 | Against |
| Jackson National | 0 | 14,920 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 12,488 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 10,211 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 7,842 | 0 | 0 | Against |
Showing the 25 largest of 39 asset managers. All 39 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
61% Approved · of votes cast
Description as filed by funds: To ratify, on a non-binding advisory basis, the compensation of our named executive officers.
ADICET BIO INC.’s own tally for this item (“5. Non-Binding Advisory Vote on Compensation of the Company's Named Executive Officers”): 29,915,289 for, 19,213,617 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5 – Non-Binding Advisory Vote on Compensation of the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding advisory basis, the compensation of the Company's named executive officers.”
Support: 61% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 3,187,084 | 0 | 0 | Against |
| BlackRock | 0 | 1,512,659 | 0 | 0 | Against |
| Fidelity | 0 | 1,063,513 | 0 | 0 | Against |
| TIAA | 0 | 197,137 | 0 | 0 | Against |
| Goldman Sachs | 0 | 183,375 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,076 | 0 | 0 | Against |
| ETF Series Solutions | 0 | 140,011 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 129,800 | 0 | 0 | Against |
| TARGET PORTFOLIO TRUST | 0 | 103,400 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 99,541 | 0 | 0 | Against |
| Equitable | 0 | 88,344 | 0 | 0 | Against |
| American Century | 0 | 58,437 | 0 | 0 | Against |
| Dimensional | 0 | 36,397 | 0 | 0 | Against |
| Lincoln Financial | 26,200 | 4,729 | 0 | 0 | Mixed |
| Pacific Life | 0 | 23,780 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 21,312 | 0 | 0 | Against |
| Nationwide | 0 | 20,746 | 0 | 0 | Against |
| Voya | 0 | 20,267 | 0 | 0 | Against |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 0 | 18,074 | 0 | 0 | Against |
| John Hancock | 0 | 16,055 | 0 | 0 | Against |
| Jackson National | 0 | 14,920 | 0 | 0 | Against |
| Principal Exchange-Traded Funds | 0 | 12,488 | 0 | 0 | Against |
| HC CAPITAL TRUST | 0 | 10,211 | 0 | 0 | Against |
| Blackstone Alternative Investment Funds | 0 | 7,842 | 0 | 0 | Against |
Fund voting reports, all 38 managers: 52,003 for, 7,156,232 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11,447,140 | 0 | 0 | 0 | For |
| RA CAPITAL MANAGEMENT, L.P. | 7,006,816 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 5,099,436 | 0 | 0 | Against |
| RTW INVESTMENTS, LP | 2,983,420 | 0 | 0 | 0 | For |
| Carlyle Group Inc. | 2,948,718 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,672,288 | 64,431 | 0 | 0 | For |
| COMMODORE CAPITAL LP | 0 | 1,374,320 | 0 | 0 | Against |
| Blackstone Inc. | 0 | 1,236,453 | 0 | 0 | Against |
| BlackRock | 11,786 | 1,105,384 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 952,058 | 0 | 0 | Against |
| Octagon Capital Advisors LP | 767,799 | 0 | 0 | 0 | For |
| Woodline Partners LP | 735,095 | 0 | 0 | 0 | For |
| Two Sigma | 0 | 626,550 | 0 | 0 | Against |
| DAFNA Capital Management LLC | 600,000 | 0 | 0 | 0 | For |
| State Street | 572,780 | 2,656 | 0 | 0 | For |
| Renaissance | 0 | 431,997 | 0 | 0 | Against |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 373,379 | 0 | 0 | Against |
| Northern Trust | 311,091 | 1,216 | 0 | 0 | For |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 248,574 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 204,366 | 0 | 0 | Against |
| Nuveen | 0 | 203,501 | 0 | 0 | Against |
| Fidelity | 0 | 200,047 | 0 | 0 | Against |
| Charles Schwab | 0 | 150,076 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 129,800 | 0 | 0 | Against |
| DE Shaw | 0 | 113,246 | 0 | 0 | Against |
Institutional-manager reports, all 78 managers: 30,088,076 for, 13,249,665 against, 27,047 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
0.2% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To ratify, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| ETF Series Solutions | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| TARGET PORTFOLIO TRUST | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Nationwide | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Managed Portfolio Series | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Principal Exchange-Traded Funds | 0 | 0 | 0 | 0 | -- |
| HC CAPITAL TRUST | 0 | 0 | 0 | 0 | -- |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 38 managers: 7,152,189 1 year, 56,046 3 year. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| RA CAPITAL MANAGEMENT, L.P. | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| RTW INVESTMENTS, LP | 0 | 0 | 0 | 0 | -- |
| Carlyle Group Inc. | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| COMMODORE CAPITAL LP | 0 | 0 | 0 | 0 | -- |
| Blackstone Inc. | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Octagon Capital Advisors LP | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| DAFNA Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 76 managers: 80 for, 35,072 against, 43,248,007 1 year, 55,828 3 year, 1,184 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 100.0% for (June 1, 2023 meeting) unchanged
Description as filed by funds: To ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
ADICET BIO INC.’s own tally for this item (“7. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 61,549,197 for, 8,657 against — passed, per its Form 8-K filed June 7, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 7 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 38 asset managers below reported 7,208,235 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,187,084 | 0 | 0 | 0 | For |
| BlackRock | 1,512,659 | 0 | 0 | 0 | For |
| Fidelity | 1,063,513 | 0 | 0 | 0 | For |
| TIAA | 197,137 | 0 | 0 | 0 | For |
| Goldman Sachs | 183,375 | 0 | 0 | 0 | For |
| Charles Schwab | 150,076 | 0 | 0 | 0 | For |
| ETF Series Solutions | 140,011 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 129,800 | 0 | 0 | 0 | For |
| TARGET PORTFOLIO TRUST | 103,400 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 99,541 | 0 | 0 | 0 | For |
| Equitable | 88,344 | 0 | 0 | 0 | For |
| American Century | 58,437 | 0 | 0 | 0 | For |
| Dimensional | 36,397 | 0 | 0 | 0 | For |
| Lincoln Financial | 30,929 | 0 | 0 | 0 | For |
| Pacific Life | 23,780 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 21,312 | 0 | 0 | 0 | For |
| Nationwide | 20,746 | 0 | 0 | 0 | For |
| Voya | 20,267 | 0 | 0 | 0 | For |
| Northern Trust | 19,898 | 0 | 0 | 0 | For |
| Managed Portfolio Series | 18,074 | 0 | 0 | 0 | For |
| John Hancock | 16,055 | 0 | 0 | 0 | For |
| Jackson National | 14,920 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 12,488 | 0 | 0 | 0 | For |
| HC CAPITAL TRUST | 10,211 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 7,842 | 0 | 0 | 0 | For |
Showing the 25 largest of 38 asset managers. All 38 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 82,173,503 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.88% |
| 2 | BlackRock | 1.84% |
| 3 | Fidelity | 1.29% |
| 4 | TIAA | 0.24% |
| 5 | Goldman Sachs | 0.22% |
| 6 | Charles Schwab | 0.18% |
| 7 | ETF Series Solutions | 0.17% |
| 8 | BRIDGEWAY FUNDS INC | 0.16% |
| 9 | TARGET PORTFOLIO TRUST | 0.13% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.12% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 13.93% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 8.53% |
| 3 | BALYASNY ASSET MANAGEMENT L.P. | 6.21% |
| 4 | RTW INVESTMENTS, LP | 3.63% |
| 5 | Carlyle Group Inc. | 3.59% |
| 6 | Goldman Sachs | 3.33% |
| 7 | COMMODORE CAPITAL LP | 1.67% |
| 8 | Blackstone Inc. | 1.50% |
| 9 | BlackRock | 1.36% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.16% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Carl L. Gordon, Ph.D. | 11,546,440 | 14.05% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| Entities affiliated with OrbiMed | 11,546,440 | 14.05% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| RA Capital Healthcare Fund, L.P. | 7,696,949 | 9.37% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| Tang Capital Partners, LP | 5,900,000 | 7.18% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| Commodore Capital Master LP | 4,250,000 | 5.17% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| RTW Investments, LP | 4,134,631 | 5.03% | Proxy statement (DEF 14A), proxy filed April 23, 2024 |
| Millennium Management | 4,106,170 | 5.00% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 3,751,617 | 4.57% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 3,272,522 | 3.98% | Form 13F, quarter ended March 31, 2024 |
| Cowen Financial Products LLC | 2,715,278 | 3.30% | Schedule 13G, filed February 2, 2024 |
Percentages above are of 82,173,503 shares outstanding, as reported by ADICET BIO INC. on its Form 10-Q dated May 10, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At ADICET BIO INC.'s shareholder meeting held June 5, 2024, in the 2023-2024 proxy season, 104 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,050 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To ratify, on a non-binding advisory basis, the compensation of our named executive officers. — ADICET BIO INC.'s filing reports the proposal as approved, with 61% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: ADICET BIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 7, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from ADICET BIO INC.’s 10-Q dated May 10, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
ADICET BIO INC. proxy season coverage: 2023-2024 (this page).
Proxy Votes Now, “ADICET BIO (ACET) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/adicet-bio-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.